Browsing by Author "Perazzo, Hugo"
Now showing items 15-34 of 67
-
Development of algorithms to estimate EQ-5D and derive health utilities from WHOQOL-HIV Bref: a mapping study
Castro, Rodolfo et al. | Date Issued: 2020 -
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference
Poynard, Thierry et al. | Date Issued: 2018 -
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
Munteanu, M. et al. | Date Issued: 2016 -
Diagnostic value of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV
Yanavich, C. et al. | Date Issued: 2021 -
Effectiveness of Direct-acting Agents After Liver Transplantation A Real-life Study in Rio de Janeiro
Pinto, Laura et al. | Date Issued: 2022 -
Effectiveness of Direct-acting Agents After Liver Transplantation and Regression of Biomarkers Post-HCV Treatment: A Real-life Study in Rio de Janeiro
Pinto, Laura et al. | Date Issued: 2022 -
Effectiveness of direct-acting agents for chronic hepatitis C treatment in South America: A systematic review and meta-analysis
Castro Filho, Elio C. et al. | Date Issued: 2020 -
Effectiveness of direct-acting agents for hepatitis C and liver stiffness changing after sustained virological response
Fernandes, Flavia F. et al. | Date Issued: 2019 -
Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis
Perazzo, Hugo et al. | Date Issued: 2020 -
Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: a systematic review with meta-analysis
Castro, Rodolfo et al. | Date Issued: 2020 -
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury
Mikus, Maria et al. | Date Issued: 2017 -
Estudo do desenvolvimento e impacto da doença hepática gordurosa não alcóolica (DGHNA) na infecção pelo HIV: novos biomarcadores, microbiota intestinal e vias funcionais para diagnóstico e avaliação da patogênese na presença de esteatose e fibrose hepática
Yanavich, Carolyn Morrissey | Date Issued: 2019Introdução: A doença hepática gordurosa não alcóolica (DHGNA) é caracterizada pelo acúmulo anormal de gordura no parênquima hepático. Trata-se de uma das principais causas de doença hepática crônica em todo o mundo e um ... -
Extended use or reuse of N95 respirators during COVID-19 pandemic: An overview of national regulatory authority recommendations
Kobayash, Leticia Mitiko et al. | Date Issued: 2020 -
Factors that could Impact on liver fibrosis staging by transient elastography
Perazzo, Hugo et al. | Date Issued: 2015 -
Frequency and predictive factors of minimal hepatic encephalopathy before and after sustained virological response in HCV cirrhosis
Piedade, Juliana et al. | Date Issued: 2022 -
Gastrointestinal endoscopy during COVID-19 pandemic: an updated review of guidelines and statements from international and national societies
Castro Filho, Elio C. et al. | Date Issued: 2020 -
Hepatitis of unknown etiology in children in Brazil: A new challenge or the usual scenario?
Castro, Rodolfo et al. | Date Issued: 2022 -
Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study
Parente, Daniella Braz et al. | Date Issued: 2020 -
Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus
Marks, Kristen M. et al. | Date Issued: 2023 -
Impact of steatosis and inflammation definitions on the performance of NASH tests
Poynard, Thierry et al. | Date Issued: 2018